Pertuzumab is a humanized HER2-specifical monoclonal antibody, which prevents the dimerization of HER2 with other HER receptors by binding to HER2 and subsequently leads to suppression of tumor growth13, 15, 16. Here, ERBB2 is linked to neoplasm.